November 9, 2017
Prof. Ryuji Kaji Tokushima University is making a fresh attempt to revive a drug candidate once jettisoned by Eisai for the treatment of amyotrophic lateral sclerosis (ALS), expecting that there would still be a group of patients who would respond...read more